Hong Kong lags on Esma equivalence


Hong Kong is lagging behind other Asian jurisdictions in gaining European Securities and Markets Authority (Esma) recognition on the equivalence of its over-the-counter derivative regulatory regime as laws to implement its OTC derivatives framework are still in the process of being passed.

In its second round of equivalence determinations on October 2, Esma has granted India and South Korea third-country regulatory conditional equivalence for central counterparties (CCPs) while Singaporean trade

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: